An active metabolite of tryptophan
Related Products
Isomer(s)
11572IOX1
Labeled Version(s)
36306Kynurenic Acid-d5
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Kynurenic Acid (hydrate)

Item No. 16792

Technical Information
Formal Name
4-hydroxy-2-quinolinecarboxylic acid, hydrate
CAS Number
345909-35-5
Synonyms
  • KYNA
Molecular Formula
C10H7NO3 • XH2O
Formula Weight
Purity
≥98%
A crystalline solid
0.1 M NaOH: 1 mg/ml
λmax
217, 247, 341 nm
SMILES
OC(C1=NC2=CC=CC=C2C(O)=C1)=O
InChi Code
InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)
InChi Key
HCZHHEIFKROPDY-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Kynurenic acid is an active metabolite of tryptophan (Item No. 29600 | 31210).1 It is formed from tryptophan via a kynurenine (Item No. 11305) intermediate by kynurenine aminotransferases (KATs). Kynurenic acid is an antagonist of the NMDA and AMPA receptors as well as α7 nicotinic acetylcholine receptors (nAChRs; EC50s = 235, 101, and 7 µM, respectively).2 It is also an agonist of the aryl hydrocarbon receptor (AhR) and G protein-coupled receptor 35 (GPR35; EC50s = 1.4 and 39 µM, respectively). It prevents lesioned hemisphere weight loss in a neonatal rat model of cerebral hypoxic-ischemia induced by carotid artery ligation when administered at a dose of 300 mg/kg.3 Kynurenic acid (1 and 5 mg/ml) is protective against rhabdomere neurodegeneration in the eye in an Htt93Q transgenic Drosophila model of Huntington's disease.4 Levels of kynurenic acid in cerebrospinal fluid are increased in patients with schizophrenia.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Schwarcz, R., Bruno, J.P., Muchowski, P.J., et alKynurenines in the mammalian brain: When physiology meets pathology. Nat. Rev. Neurosci. 13(7), 465-477 (2012).

    2. Turski, M.P., Turska, M., Paluszkiewicz, P., et alKynurenic acid in the digestive system-new facts, new challenges. Int. J. Tryptophan Res. 6, 47-55 (2013).

    3. Andiné, P., Lehmann, A., Ellrén, K., et alThe excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Neurosci. Lett. 90(1-2), 208-212 (1988).

    4. Campesan, S., Green, E.W., Breda, C., et alThe kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington’s disease. Curr. Biol. 21(11), 9611-9966 (2011).

    5. Nilsson, L.K., Linderholm, K.R., Engberg, G., et alElevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr. Res. 80(2-3), 315-322 (2005).